Arcadia Biosciences, Inc. (RKDA) Has Another Very Strong Trading Session

March 14, 2018 - By Clifton Ray

The stock of Arcadia Biosciences, Inc. (NASDAQ:RKDA) is a huge mover today! The stock increased 332.73% or $38.83 during the last trading session, reaching $50.5. About 12.75 million shares traded or 8270.17% up from the average. Arcadia Biosciences, Inc. (NASDAQ:RKDA) has declined 43.32% since March 14, 2017 and is downtrending. It has underperformed by 60.02% the S&P500.
The move comes after 9 months positive chart setup for the $107.78 million company. It was reported on Mar, 14 by We have $54.54 PT which if reached, will make NASDAQ:RKDA worth $8.62 million more.

Analysts await Arcadia Biosciences, Inc. (NASDAQ:RKDA) to report earnings on March, 20 after the close. They expect $-2.00 EPS, up 23.08 % or $0.60 from last year’s $-2.6 per share. After $-2.20 actual EPS reported by Arcadia Biosciences, Inc. for the previous quarter, Wall Street now forecasts -9.09 % EPS growth.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Ratings Coverage

Among 2 analysts covering Arcadia Biosciences (NASDAQ:RKDA), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Arcadia Biosciences had 2 analyst reports since May 12, 2017 according to SRatingsIntel. Piper Jaffray maintained Arcadia Biosciences, Inc. (NASDAQ:RKDA) on Friday, July 21 with “Hold” rating. On Friday, May 12 the stock rating was downgraded by PiperJaffray to “Neutral”.

More notable recent Arcadia Biosciences, Inc. (NASDAQ:RKDA) news were published by: which released: “Arcadia Biosciences, Inc. (RKDA) and United States Steel Corp. (X) Activist Update” on March 11, 2018, also with their article: “Mid-Afternoon Market Update: Intellia Therapeutics Slides Following Q4 Results …” published on March 14, 2018, published: “Arcadia continues rally, up 65%” on March 12, 2018. More interesting news about Arcadia Biosciences, Inc. (NASDAQ:RKDA) were released by: and their article: “Arcadia Biosciences Inc.” published on May 10, 2017 as well as‘s news article titled: “UPDATE: Arcadia Biosciences stock surges 260% after news company has met …” with publication date: March 14, 2018.

Arcadia Biosciences, Inc., an agricultural biotechnology trait company, develops traits that enhance food, feed, and fiber crops worldwide. The company has market cap of $107.78 million. The firm offers a suite of agricultural yield traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, herbicide tolerance, and heat tolerance traits, as well as yield and agronomic trait stacks primarily for food crops, such as corn, rice, wheat, and soybean. It currently has negative earnings. It also provides agricultural product quality traits comprising gamma linolenic acid safflower oil to manufacturers of nutritional supplements, medical foods, and other products under the SONOVA brand; and arachidonic acid safflower oil that is used as an ingredient in infant nutrition products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: